Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Clinics ; 71(6): 351-360, tab, graf
Article in English | LILACS | ID: lil-787429

ABSTRACT

OBJECTIVE: To evaluate the functional and histological effects of ganglioside G(M1) and erythropoietin after experimental spinal cord contusion injury. METHODS: Fifty male Wistar rats underwent experimental spinal cord lesioning using an NYU-Impactor device and were randomly divided into the following groups, which received treatment intraperitoneally. The G(M1) group received ganglioside G(M1) (30 mg/kg); the erythropoietin group received erythropoietin (1000 IU/kg); the combined group received both drugs; and the saline group received saline (0.9%) as a control. A fifth group was the laminectomy group, in which the animals were subjected to laminectomy alone, without spinal lesioning or treatment. The animals were evaluated according to the Basso, Beattie and Bresnahan (BBB) scale, motor evoked potential recordings and, after euthanasia, histological analysis of spinal cord tissue. RESULTS: The erythropoietin group had higher BBB scores than the G(M1) group. The combined group had the highest BBB scores, and the saline group had the lowest BBB scores. No significant difference in latency was observed between the three groups that underwent spinal cord lesioning and intervention. However, the combined group showed a significantly higher signal amplitude than the other treatment groups or the saline group (p<0.01). Histological tissue analysis showed no significant difference between the groups. Axonal index was significantly enhanced in the combined group than any other intervention (p<0.01). CONCLUSION: G(M1) and erythropoietin exert therapeutic effects on axonal regeneration and electrophysiological and motor functions in rats subjected to experimental spinal cord lesioning and administering these two substances in combination potentiates their effects.


Subject(s)
Animals , Male , Erythropoietin/pharmacology , G(M1) Ganglioside/pharmacology , Neuroprotective Agents/pharmacology , Recovery of Function/drug effects , Spinal Cord Injuries/drug therapy , Drug Therapy, Combination , Erythropoietin/therapeutic use , G(M1) Ganglioside/therapeutic use , Injections, Intraperitoneal , Locomotion/drug effects , Models, Animal , Necrosis , Random Allocation , Rats, Wistar , Reaction Time/drug effects , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology
2.
Braz. j. med. biol. res ; 44(6): 553-561, June 2011. ilus
Article in English | LILACS | ID: lil-589973

ABSTRACT

White matter injury characterized by damage to myelin is an important process in hypoxic-ischemic brain damage (HIBD). Because the oligodendrocyte-specific isoform of neurofascin, neurofascin 155 (NF155), and its association with lipid rafts are essential for the establishment and stabilization of the paranodal junction, which is required for tight interaction between myelin and axons, we analyzed the effect of monosialotetrahexosyl ganglioside (GM1) on NF155 expression and its association with lipid rafts after HIBD in Sprague-Dawley rats, weighing 12-15 g, on day 7 post-partum (P7; N = 20 per group). HIBD was induced on P7 and the rats were divided into two groups: one group received an intraperitoneal injection of 50 mg/kg GM1 three times and the other group an injection of saline. There was also a group of 20 sham-operated rats. After sacrifice, the brains of the rats were removed on P30 and studied by immunochemistry, SDS-PAGE, Western blot analysis, and electron microscopy. Staining showed that the saline group had definite rarefaction and fragmentation of brain myelin sheaths, whereas the GM1 group had no obvious structural changes. The GM1 group had 1.9-2.9-fold more GM1 in lipid rafts than the saline group (fraction 3-6; all P < 0.05) and 0.5-2.4-fold higher expression of NF155 in lipid rafts (fraction 3-5; all P < 0.05). Injection of GM1 increased the content of GM1 in lipid rafts as well as NF155 expression and its lipid raft association in HIBD rat brains. GM1 may repair the structure of lipid rafts, promote the association of NF155 (or other important proteins) with lipid rafts, stabilize the structure of paranodes, and eventually prevent myelin sheath damage, suggesting a novel mechanism for its neuroprotective properties.


Subject(s)
Animals , Female , Male , Rats , Cell Adhesion Molecules/metabolism , G(M1) Ganglioside/metabolism , G(M1) Ganglioside/pharmacology , Hypoxia-Ischemia, Brain/metabolism , Membrane Lipids/metabolism , Myelin Sheath/drug effects , Nerve Growth Factors/metabolism , Animals, Newborn , Blotting, Western , Brain/ultrastructure , Hypoxia-Ischemia, Brain/pathology , Injections, Intraperitoneal , Microscopy, Electron , Myelin Sheath/metabolism , Myelin Sheath/pathology , Random Allocation , Rats, Sprague-Dawley
3.
Braz. j. med. biol. res ; 43(10): 942-949, Oct. 2010. ilus
Article in English | LILACS | ID: lil-561222

ABSTRACT

Recent studies have reported that exogenous gangliosides, the sialic acid-containing glycosphingolipids, are able to modulate many cellular functions. We examined the effect of micelles of mono- and trisialoganglioside GM1 and GT1b on the production of reactive oxygen species by stimulated human polymorphonuclear neutrophils using different spectroscopic methods. The results indicated that exogenous gangliosides did not influence extracellular superoxide anion (O2.-) generation by polymorphonuclear neutrophils activated by receptor-dependent formyl-methionyl-leucyl-phenylalanine. However, when neutrophils were stimulated by receptor-bypassing phorbol 12-myristate 13-acetate (PMA), gangliosides above their critical micellar concentrations prolonged the lag time preceding the production in a concentration-dependent way, without affecting total extracellular O2.- generation detected by superoxide dismutase-inhibitable cytochrome c reduction. The effect of ganglioside GT1b (100 µM) on the increase in lag time was shown to be significant by means of both superoxide dismutase-inhibitable cytochrome c reduction assay and electron paramagnetic resonance spectroscopy (P < 0.0001 and P < 0.005, respectively). The observed phenomena can be attributed to the ability of ganglioside micelles attached to the cell surface to slow down PMA uptake, thus increasing the diffusion barrier and consequently delaying membrane events responsible for PMA-stimulated O2.- production.


Subject(s)
Humans , G(M1) Ganglioside/pharmacology , Gangliosides/pharmacology , Neutrophils/drug effects , Reactive Oxygen Species/metabolism , Superoxide Dismutase/biosynthesis , Cytochromes c/pharmacology , Electron Spin Resonance Spectroscopy , Micelles , Neutrophils/metabolism
4.
Clinics ; 63(3): 375-380, 2008. ilus, graf, tab
Article in English | LILACS | ID: lil-484764

ABSTRACT

OBJECTIVES: The pharmacological effects of methylprednisolone (MP) and ganglioside GM-1 on spinal injuries have been thoroughly investigated, but only a few studies have evaluated the interaction between these two drugs. METHODS: Twenty-four Wistar rats were subjected to contusive injury of the spinal cord produced by the NYU system. These animals were divided into four groups: group I was injected with MP; group II was injected with GM-1; group III was injected with MP together with GM-1; and group control received physiological serum. The animals were evaluated with regard to their recovery of locomotive function by means of the BBB test on the second, seventh and fourteenth days after receiving the contusive injury to the spinal cord. They were sacrificed on the fourteenth day. RESULTS: This study demonstrated that the MP and GM-1 groups presented functional results that were better than those of the control group, although the enhanced recovery of group II (GM-1) relative to the control group was not statistically significant (p>0.05). The most notable recovery of locomotive function was observed in the group that received MP alone (p<0.05). The group that received MP together with GM-1 presented results that were better than those of the control group (p<0.05). CONCLUSION: Administration of methylprednisolone alone or with GM-1 was shown to be effective for recovery of locomotive function. Combined administration of these drugs resulted in better outcomes than administration of methylprednisolone alone.


Subject(s)
Animals , Male , Rats , Anti-Inflammatory Agents/therapeutic use , G(M1) Ganglioside/therapeutic use , Methylprednisolone/therapeutic use , Motor Activity/drug effects , Spinal Cord Injuries/drug therapy , Anti-Inflammatory Agents/pharmacology , Disease Models, Animal , Drug Evaluation, Preclinical , Drug Therapy, Combination , G(M1) Ganglioside/pharmacology , Methylprednisolone/pharmacology , Rats, Wistar , Recovery of Function/drug effects , Statistics, Nonparametric , Treatment Outcome
5.
Journal of Korean Medical Science ; : 179-187, 1994.
Article in English | WPRIM | ID: wpr-145192

ABSTRACT

Human neuroblastoma SH-SY5Y cell is a cloned cell line which has many attractive features for the study of neuronal proliferation and neurite outgrowth, because it has receptors for insulin, IGF-I and PDGF. Gangliosides are sialic acid containing glycosphingolipids which form an integral part of the plasma membrane of many mammalian cells. They inhibit cell growth mediated by tyrosine kinase receptors and ligand-stimulated tyrosine kinase activity, and autophosphorylation of EGF(epidermal growth factor) and PDGF receptors. The experiment was designed to study the effects of GM1 ganglioside on growth of human neuroblastoma SH-SY5Y cells stimulated with trophic factor in vitro. The cells were plated in Eagle's minimum essential medium without serum. The number and morphologic change of SH-SY5Y cells were evaluated in the serum free medium added GM1 ganglioside with insulin or PDGF. SH-SY5Y cells were maintained for six days in serum-free medium, and then cultured for over two weeks in serum-free medium containing either insulin or PDGF. The effect of insulin on cell proliferation developed earlier and was more potent than that of PDGF. These proliferative effects were inhibited by GM1 ganglioside, and the cells showed prominent neurites outgrowth. These findings suggest that GM1 ganglioside inhibits the cell proliferation mediated by tyrosine kinase receptors and directly induces neuritogenesis as one of the neurotrophic factors.


Subject(s)
Humans , Cell Differentiation/drug effects , Cell Division/drug effects , G(M1) Ganglioside/pharmacology , Insulin/pharmacology , Neuroblastoma , Neurons/cytology , Platelet-Derived Growth Factor/pharmacology , Receptor Protein-Tyrosine Kinases/drug effects , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL